Unlocking Parkinson’s disease: the role of microRNAs in regulation, diagnosis, and therapy
Authors:
- 1 May 2025
- journal article
- review article
- Published by Springer Nature in Apoptosis
- Vol. 30 (5-6) , 1272-1291
Abstract
Parkinson’s disease (PD), the second most prevalent neurodegenerative disorder globally, imposes substantial healthcare burdens on aging populations. The pathogenesis of PD is complex and multifaceted. Emerging evidence highlights microRNA (miRNA) dysregulation as a critical regulatory layer that drives PD progression. These small noncoding RNAs mediate posttranscriptional gene regulation through target mRNA binding, inducing either transcript degradation or translational repression. This article reviews the distinct miRNAs that orchestrate PD pathogenesis by disrupting mitochondrial homeostasis, lysosomal clearance pathways, ferroptosis regulation, and neuroinflammatory responses. Notably, some miRNAs achieve these effects by selectively targeting risk genes central to PD pathology. Crucially, certain miRNAs exhibit aberrant expression patterns in the brain tissues and biofluids of PD patients or models, highlighting their potential as minimally invasive diagnostic or prognostic biomarkers. Furthermore, this review highlights the novel role of exosomes as miRNA carriers, offering innovative possibilities for PD therapeutic interventions. With the deepening understanding of miRNA research advances in PD, we propose that these insights may not only inform PD treatment strategies but also hold relevance for addressing other genetic disorders.Keywords
Funding Information
- National Natural Science Foundation of China (82071676)
This publication has 213 references indexed in Scilit:
- Exosomes in brain diseases: Pathogenesis and therapeutic targetsMedcomm, 2023
- Parkinson's Disease Derived Exosomes Aggravate Neuropathology in SNCA*A53T MiceAnnals of Neurology, 2022
- The role of mitochondrial dysfunction in Alzheimer's disease pathogenesisAlzheimer's & Dementia, 2022
- Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease ProgressionJAMA Network Open, 2021
- Effective inhibition of miR‐330/SHIP1/NF‐κB signaling pathway via miR‐330 sponge repolarizes microglia differentiationCell Biology International, 2020
- Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patientsAnnals of Clinical and Translational Neurology, 2020
- Down regulation of miR‐218, miR‐124, and miR‐144 relates to Parkinson's disease via activating NF‐κB signalingThe Kaohsiung Journal of Medical Sciences, 2020
- MicroRNA‐190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP‐induced Parkinson's disease mouse modelJournal of Cellular Physiology, 2019
- Meta‐analyses identify differentially expressed microRNAs in Parkinson's diseaseAnnals of Neurology, 2019
- miR‐9 regulates ferroptosis by targeting glutamic‐oxaloacetic transaminase GOT1 in melanomaMolecular Carcinogenesis, 2018